CD274 and malignant colon neoplasm: In patients with colon cancer, m1A modification is associated with the proliferation of CD8+ T effectors, in addition to high microsatellite instability, neoantigen burden, and PD‐L1 expression, thus demonstrating prolonged survival and better response to anti‐PD‐L1 immunotherapy.13